1-20 of 46
Li Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Experience of Ropeginterferon-Alfa Treatment of PV and ET - Two Centers Experience

Tsewang Tashi, Brandi N. Reeves, Soo Jin Kim, Hyewon Jeong, Sheh-Li Chen, Brynn Parsegov, Josef T. Prchal
Journal: Blood
Blood (2023) 142 (Supplement 1): 6397.
https://doi.org/10.1182/blood-2023-191268
Published: 2023
Journal Articles

Recommendations on Minimal Residual Disease Monitoring in Acute Promyelocytic Leukemia Treated with Combination of All- Trans Retinoic Acid and Arsenic Trioxide

Li Chen, Hongming Zhu, Fangyi Dong, Yan Li, Qifa Liu, Yu Hu, Yicheng Zhang, Jie Jin, Jianda Hu, Ting Liu, Depei Wu, Jieping Chen, Yongrong Lai, Jianxiang Wang, Juan Li, Jianyong Li, Xin Du, Xin Wang, Mingzhen Yang, Jinsong Yan, Guifang Ouyang, Li Liu, Ming Hou, Xiaojun Huang, Wen Jin, Yongmei Zhu, Jian Li, Kankan Wang, Zhu Chen, Sai-Juan Chen, Junmin Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 2946.
https://doi.org/10.1182/blood-2023-184433
Published: 2023
Journal Articles

Older Adults with Acute Myeloid Leukemia (AML) Experience Improvement in Health-Related Quality of Life (HRQoL) Scores with Intensive Therapy: Prospective Study from ECOG-ACRIN (EA) E2906 Phase 3 Trial

James M. Foran, Li Chen, Selina M Luger, Zhuoxin Sun, Heidi Klepin, David F. Claxton, Hillard M. Lazarus, Jacob M. Rowe, Jessica K. Altman, Aref Al-Kali, Hong Zheng, Keith W Pratz, Edward R. Broun, Bayard L Powell, Kristen M. O'Dwyer, Yishai Ofran, John E. Godwin, Mark R. Litzow, Martin S. Tallman, Lynne Wagner
Journal: Blood
Blood (2023) 142 (Supplement 1): 594.
https://doi.org/10.1182/blood-2023-189734
Published: 2023
Journal Articles

Ropegiterferon Alfa-2b-Njft for Treatment Myeloproliferative Neoplasms: A Single Institution Experience

Callie Berkowitz, Sheh-Li Chen, Brandi Reeves
Journal: Blood
Blood (2022) 140 (Supplement 1): 12254–12255.
https://doi.org/10.1182/blood-2022-164733
Published: 2022
Journal Articles

Recurrent noncoding somatic and germline WT1 variants converge to disrupt MYB binding in acute promyelocytic leukemia

Huan Song, Yabin Liu, Yun Tan, Yi Zhang, Wen Jin, Li Chen, Shishuang Wu, Jinsong Yan, Junmin Li, Zhu Chen, Saijuan Chen, Kankan Wang
Journal: Blood
Blood (2022) 140 (10): 1132–1144.
https://doi.org/10.1182/blood.2021014945
Published: 2022
Includes: Supplemental data
Journal Articles

Rituximab Monotherapy Is Effective for Inhibitor Eradication with Concomitant Porcine Factor VIII Followed By Emicizumab for Bleed Control in Acquired Hemophilia a

Patrick Ellsworth, Sheh-Li Chen, Christopher Wang, Nigel S Key, Alice Ma
Journal: Blood
Blood (2021) 138 (Supplement 1): 348.
https://doi.org/10.1182/blood-2021-154207
Published: 2021
Journal Articles

Incidence and Time Course of Neutropenia in Patients Treated with Rituximab-Based Therapy for Non-Malignant Immune-Mediated Hematologic Diseases

Luis E Malpica Castillo, MD, Shannon Palmer, MS, Allison Deal, MS, Sheh-Li Chen, PharmD, Anqi Zhu, MS, Stephan Moll, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 390.
https://doi.org/10.1182/blood-2019-121343
Published: 2019
Journal Articles

Enhancing Anti-Tumor Immunity and Responses to Immune Checkpoint Blockade By Suppressing Interleukin-10 in Chronic Lymphocytic Leukemia

Jacqueline R. Rivas, PhDBS, Sara S. Alhakeem, PhD, Joseph M. Eckenrode, PhD, Yinan Zhang, PhD, James P. Collard, BS, Gerhard C. Hildebrandt, MD, Roger A. Fleischman, MD PhD, Li Chen, PhD, Jon S. Thorson, PhD, Markos Leggas, PhD, Subbarao Bondada, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5486.
https://doi.org/10.1182/blood-2019-127178
Published: 2019
Journal Articles

In silico Prediction Followed By in Vitro validation Identifies the Survivin Inhibitor YM155 As a Potent Secondary Drug Against Pi-Resistant Myeloma

Harish Kumar, PhD, Ujjal Kumar Mukherjee, PhD, Li Chen, PhD, Amit Kumar Mitra, PhD MSc, BSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 5543.
https://doi.org/10.1182/blood-2019-131923
Published: 2019
Journal Articles

Adherence to Infectious Disease Screening and Immunization Guidelines When Treating Non-Malignant Immune-Mediated Hematologic Disorders

Luis E Malpica Castillo, MD, Shannon Palmer, MS, Anqi Zhu, MS, Allison Deal, MS, Sheh-Li Chen, PharmD, Stephan Moll, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 792.
https://doi.org/10.1182/blood-2019-121340
Published: 2019
Journal Articles

Secdrug: A Computational Method for Discovering Novel Secondary Drug Combinations Using Large-Scale Pharmacogenomics Databases

Li Chen, PhD, Ujjal Kumar Mukherjee, PhD, Emily Rankine, Brian G. Van Ness, PhD, Amit Kumar Mitra, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4473.
https://doi.org/10.1182/blood-2018-99-117653
Published: 2018
Journal Articles

Recombinant Porcine FVIII in Acquired Hemophilia: Decreased Product Usage When Used Upfront, Non-Utility of Baseline Porcine Bethesda Titer, and Confirmation of Dosing Algorithm

Patrick Ellsworth, MD, Sheh-Li Chen, PharmD, Nigel S. Key, MBChB, FRCP, Raj S. Kasthuri, MD, Micah J. Mooberry, MD, Alice D. Ma, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2474.
https://doi.org/10.1182/blood-2018-99-118839
Published: 2018
Journal Articles

Recombinant Porcine Factor VIII Use in Bleed Treatment in Non-Severe Hemophilia a Inhibitor Patients: Dosing Strategies and Efficacy

Patrick Ellsworth, MD, Sheh-Li Chen, PharmD, Yasmina L. Abajas, MD, Stephan Moll, MD, Nigel S. Key, MBChB, FRCP, Alice D. Ma, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1202.
https://doi.org/10.1182/blood-2018-99-119196
Published: 2018
Journal Articles

Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function

Steven D. Scoville, Ansel P. Nalin, Luxi Chen, Li Chen, Michael H. Zhang, Kathleen McConnell, Susana Beceiro Casas, Gabrielle Ernst, Abd Al-Rahman Traboulsi, Naima Hashi, Monica Williams, Xiaoli Zhang, Tiffany Hughes, Anjali Mishra, Don M. Benson, Jennifer N. Saultz, Jianhua Yu, Aharon G. Freud, Michael A. Caligiuri, Bethany L. Mundy-Bosse
Journal: Blood
Blood (2018) 132 (17): 1792–1804.
https://doi.org/10.1182/blood-2018-03-838474
Published: 2018
Includes: Supplemental data
Journal Articles

A Unique N-Phenylbenzamide Inhibitor Targeting Non-Receptor Tyrosine Kinases Potently Suppresses AML Cell Growth In Vitro and In Vivo

Mark C Weir, PhD, Sherry Shu, PhD, Sabine Hellwig, PhD, Ravi Patel, Li Chen, PhD, Li Tan, PhD, Nathanael Gray, PhD, Thomas Smithgall, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3813.
https://doi.org/10.1182/blood.V130.Suppl_1.3813.3813
Published: 2017
Journal Articles

Enhanced Spontaneous Anti-Tumor Cytotoxicity of Natural Killer Cells in Cutaneous T-Cell Lymphoma Patients

Bethany L Mundy-Bosse, PhD, Nathan Denlinger, MS, DO, Susan Huang, MD, Li Chen, Hsiaoyin Mao, David Kline, Eric McLaughlin, Youssef Youssef, Karen Young, Gerard Lozanski, MD, Aharon G. Freud, MD PhD, Pierluigi Porcu, MD, Basem M. William, MD, Michael A. Caligiuri, MD, Anjali Mishra, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2753.
https://doi.org/10.1182/blood.V130.Suppl_1.2753.2753
Published: 2017
Journal Articles

Influence of Body Mass Index on Incidence and Prognosis of Acute Myeloid Leukemia and Acute Promyelocytic Leukemia: A Systematic Review and Meta-Analysis

Shufen Li, Li Chen, Kankan Wang, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5023.
https://doi.org/10.1182/blood.V130.Suppl_1.5023.5023
Published: 2017
Journal Articles

RNA:m 5 c/Methyltransferases Mediate Chromatin Organization and 5-Azacytidine Response/Resistance in Leukemia

Jason Cheng, MD PhD, Li Chen, PhD MD, Yuan Li, MD, Ming Yue, PhD, Adam Cloe, MD, PhD, Jamile M. Shammo, MD FASCP, FACP, Richard A. Larson, MD, Chuan He, PhD, Michelle M. Le Beau, PhD, James W. Vardiman, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2471.
https://doi.org/10.1182/blood.V130.Suppl_1.2471.2471
Published: 2017
Journal Articles

Retinoic Acid and Arsenic Trioxide with or without Chemotherapy for Acute Promyelocytie Leukemia with Different Risk Stratifications: A Interim Analysis of China APL 2012 Study

Junmin Li, Prof., Li Chen, Hongming Zhu, Jiong Hu, PhD/MD, Bing Chen, Xiaoyang Li, Lining Wang, Yunxiang Zhang, Yuhong Ren, Huijin Zhao, Yu Chen, Huiping Sun, Qiusheng Chen, Yu Chen, Weili Zhao, MD PhD, Jianqing Mi, Zhixiang Shen, MD, Zhenyi Wang, Zhu Chen, Saijuan Chen
Journal: Blood
Blood (2016) 128 (22): 445.
https://doi.org/10.1182/blood.V128.22.445.445
Published: 2016
Journal Articles

Bromodomain and Extra-Terminal Motif Proteins (BETs) Mediate 5-Azacitidine Resistance in Myeloid Leukemia through Recruitment of an Active RNA Polymerase II Complex

Li Chen, MD PhD, Yuan Li, MD, Ming Yue, PhD, Adam Cloe, MD PhD, Michelle M. Le Beau, PhD, Chuan He, PhD, Richard A. Larson, MD, James W. Vardiman, MD, Jason X. Cheng, MD PhD
Journal: Blood
Blood (2016) 128 (22): 746.
https://doi.org/10.1182/blood.V128.22.746.746
Published: 2016